In Vivo Effect of Rosiglitazone Combined with All-Trans Retinoic Acid on the Expression of COX-2、MMP-7、TIMP-1 of Rectal Cancer HCT-15 Cells

WANG Meng,MIAO Rui-zheng,XU Tao,GUO Ren-le,JIANG Yan-ming
DOI: https://doi.org/10.3969/j.issn.1009-9905.2011.07.001
2011-01-01
Abstract:Objective: To investigate the effect of rosiglitazone(ROS) combined with all-trans retinoic acid(ATRA) on the expression of COX-2、MMP-7、TIMP-1 of transplanted rectal cancer in nude mice,and to explore the mechanism of anti-carcinoma preliminarily.Methods: Established the modle of transplanted tumor in node mice by inoculating human rectal cancer cell line HCT-15 into the right back of nude mice subcutaneously.The cancer-bearing nude mice were divided randomly into 4 groups: group 1 with no drugs,group 2 with ROS(ROS 25 mg)·kg-1·2d-1,group 3 with ATRA(ATRA 11 mg·kg-1·2d-1),group 4 ROS combined with ATRA [(ROS 25 mg+ ATRA 11mg)·kg-1·2d-1].After treated for 40 days,the volume change of tumor were observed.The expression of COX-2、MMP-7、TIMP-1 in transplanted tumor cells were detected by immunohistochemical.Results: 1)The volumes of tumor were significantly decreased in group 2、3、4 compared with group 1(P0.05),The volume of tumor in group 4 was significantly decreased compared with group 2、3(P0.05),The volume of tumor in group 2 was similar to group3(P0.05).2)The expression of COX-2、MMP-7、TIMP-1 in transplanted tumor were significantly decreased in group 2、3、4 compared with group 1(P0.05),The expression of COX-2、MMP-7、TIMP-1 in group 4 were significantly decreased compared with group 2、3(P0.01).The expression of these three in group2 and group3 were quite(P0.05).Conclusion: ROS and ATRA can inhibit the growth of tumor and ROS combined with ATRA can further inhibit the growth of tumor.The mechanism maybe that ROS and ATRA can inhibit expression of COX-2、MMP-7、TIMP-1.
What problem does this paper attempt to address?